| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledging Patient Heterogeneity in Economic Evaluations in Schizophrenia: A Systematic Review
|
Shields, Gemma E.
|
|
|
25 |
1 |
p. 147-156
|
artikel
|
| 2 |
A Perspective on Suitability of a Cost-Based Pricing Methodology for Repurposed Orphan Medicines: A Consideration of the Overall Value Proposition
|
Zozulya Weidenfeller, Alla
|
|
|
25 |
1 |
p. 157-158
|
artikel
|
| 3 |
A Pregnant Pause: Rethinking Economic Evaluation in Contraception and Pregnancy
|
Abel, Lucy
|
|
|
25 |
1 |
p. 32-35
|
artikel
|
| 4 |
Assessment of Medical Expenditure for Patients With Breast Cancer in China: Evidence From Current Curative Expenditure by System of Health Accounts 2011
|
Zheng, Ang
|
|
|
25 |
1 |
p. 77-83
|
artikel
|
| 5 |
A Systematic Review of Health Technology Assessments of Chimeric Antigen Receptor T-Cell Therapies in Young Compared With Older Patients
|
Gye, Amy
|
|
|
25 |
1 |
p. 47-58
|
artikel
|
| 6 |
Author Reply
|
van den Berg, Sibren
|
|
|
25 |
1 |
p. 158-159
|
artikel
|
| 7 |
CHEERS to Updated Guidelines for Reporting Health Economic Evaluations!
|
Willke, Richard J.
|
|
|
25 |
1 |
p. 1-2
|
artikel
|
| 8 |
Comparing Modeling Approaches for Discrete Event Simulations With Competing Risks Based on Censored Individual Patient Data: A Simulation Study and Illustration in Colorectal Cancer
|
Degeling, Koen
|
|
|
25 |
1 |
p. 104-115
|
artikel
|
| 9 |
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force
|
Husereau, Don
|
|
|
25 |
1 |
p. 10-31
|
artikel
|
| 10 |
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations
|
Husereau, Don
|
|
|
25 |
1 |
p. 3-9
|
artikel
|
| 11 |
Copyright/Subscription
|
|
|
|
25 |
1 |
p. v
|
artikel
|
| 12 |
Do Cost-Effectiveness Analyses Account for Drug Genericization? A Literature Review and Assessment of Implications
|
Neumann, Peter J.
|
|
|
25 |
1 |
p. 59-68
|
artikel
|
| 13 |
Editorial Board
|
|
|
|
25 |
1 |
p. vi
|
artikel
|
| 14 |
Patterns of Medical Care Cost by Service Type for Patients With Recurrent and De Novo Advanced Cancer
|
Banegas, Matthew P.
|
|
|
25 |
1 |
p. 69-76
|
artikel
|
| 15 |
Reevaluating the Evidence for Intensive Postoperative Extracolonic Surveillance for Nonmetastatic Colorectal Cancer
|
Popp, Jonah
|
|
|
25 |
1 |
p. 36-46
|
artikel
|
| 16 |
Systematic Review of Cost-Effectiveness Models in Prostate Cancer: Exploring New Developments in Testing and Diagnosis
|
Keeney, Edna
|
|
|
25 |
1 |
p. 133-146
|
artikel
|
| 17 |
Table of Contents
|
|
|
|
25 |
1 |
p. i-iv
|
artikel
|
| 18 |
The Health Value of Kidney Exchange and Altruistic Donation
|
Glorie, Kristiaan
|
|
|
25 |
1 |
p. 84-90
|
artikel
|
| 19 |
The ICEpop Capability Measure for Adults Instrument for Capabilities: Development of a Tariff for the Dutch General Population
|
Rohrbach, Pieter J.
|
|
|
25 |
1 |
p. 125-132
|
artikel
|
| 20 |
The Optimal Sample Size for Usability Testing, From the Manufacturer’s Perspective: A Value-of-Information Approach
|
Caron, Alexandre
|
|
|
25 |
1 |
p. 116-124
|
artikel
|
| 21 |
Varying Willingness to Pay Based on Severity of Illness: Impact on Health Technology Assessment Outcomes of Inpatient and Outpatient Drug Therapies in The Netherlands
|
Schurer, Marieke
|
|
|
25 |
1 |
p. 91-103
|
artikel
|
Tijdschrift beschrijving